Global Inactivated Polio Vaccine Market Research Report 2026(Status and Outlook)
Polio vaccines can be classified into two types: the inactivated polio vaccine (IPV) and oral polio vaccine. Oral polio vaccine is more active than IPV as it has both weakened and live poliovirus. Inactivated polio vaccine is a vaccine prepared from suspension of inactivated (killed) poliovirus strains with formalin. It is an injectable vaccine that can either be given alone or with other vaccines. IPV has the ability to provide serum immunity against all the three types of poliovirus and consequent protection against paralytic poliomyelitis. The oral polio vaccine has the risk of transmission through human waste, causing the regulatory bodies to shift their demand towards IPV. Inactivated polio vaccines (IPV) have now been introduced into all countries? routine immunization programmes, which are strengthening the fight to eradicate wild poliovirus (WPV).The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Inactivated Polio Vaccine market size was estimated at USD 744.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Inactivated Polio Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Inactivated Polio Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Inactivated Polio Vaccine market.
Global Inactivated Polio Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
Panacea Biotec
Bio-Med
Halfkin Bio-Pharmaceuticals
Market Segmentation (by Type)
Government
Private Sector
Market Segmentation (by Application)
Pediatrics
Adults
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Inactivated Polio Vaccine Market
Overview of the regional outlook of the Inactivated Polio Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Inactivated Polio Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Inactivated Polio Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Inactivated Polio Vaccine market size was estimated at USD 744.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Inactivated Polio Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Inactivated Polio Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Inactivated Polio Vaccine market.
Global Inactivated Polio Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
Panacea Biotec
Bio-Med
Halfkin Bio-Pharmaceuticals
Market Segmentation (by Type)
Government
Private Sector
Market Segmentation (by Application)
Pediatrics
Adults
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Inactivated Polio Vaccine Market
Overview of the regional outlook of the Inactivated Polio Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Inactivated Polio Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Inactivated Polio Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Inactivated Polio Vaccine
1.2 Key Market Segments
1.2.1 Inactivated Polio Vaccine Segment by Type
1.2.2 Inactivated Polio Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INACTIVATED POLIO VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Inactivated Polio Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Inactivated Polio Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INACTIVATED POLIO VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Inactivated Polio Vaccine Product Life Cycle
3.3 Global Inactivated Polio Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Inactivated Polio Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Inactivated Polio Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Inactivated Polio Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Inactivated Polio Vaccine Market Competitive Situation and Trends
3.8.1 Inactivated Polio Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Inactivated Polio Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INACTIVATED POLIO VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Inactivated Polio Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INACTIVATED POLIO VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Inactivated Polio Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Inactivated Polio Vaccine Market
5.7 ESG Ratings of Leading Companies
6 INACTIVATED POLIO VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Inactivated Polio Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Inactivated Polio Vaccine Market Size by Type (2020-2025)
6.4 Global Inactivated Polio Vaccine Price by Type (2020-2025)
7 INACTIVATED POLIO VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Inactivated Polio Vaccine Market Sales by Application (2020-2025)
7.3 Global Inactivated Polio Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Inactivated Polio Vaccine Sales Growth Rate by Application (2020-2025)
8 INACTIVATED POLIO VACCINE MARKET SALES BY REGION
8.1 Global Inactivated Polio Vaccine Sales by Region
8.1.1 Global Inactivated Polio Vaccine Sales by Region
8.1.2 Global Inactivated Polio Vaccine Sales Market Share by Region
8.2 Global Inactivated Polio Vaccine Market Size by Region
8.2.1 Global Inactivated Polio Vaccine Market Size by Region
8.2.2 Global Inactivated Polio Vaccine Market Size by Region
8.3 North America
8.3.1 North America Inactivated Polio Vaccine Sales by Country
8.3.2 North America Inactivated Polio Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Inactivated Polio Vaccine Sales by Country
8.4.2 Europe Inactivated Polio Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Inactivated Polio Vaccine Sales by Region
8.5.2 Asia Pacific Inactivated Polio Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Inactivated Polio Vaccine Sales by Country
8.6.2 South America Inactivated Polio Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Inactivated Polio Vaccine Sales by Region
8.7.2 Middle East and Africa Inactivated Polio Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INACTIVATED POLIO VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Inactivated Polio Vaccine by Region(2020-2025)
9.2 Global Inactivated Polio Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Inactivated Polio Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Inactivated Polio Vaccine Production
9.4.1 North America Inactivated Polio Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Inactivated Polio Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Inactivated Polio Vaccine Production
9.5.1 Europe Inactivated Polio Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Inactivated Polio Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Inactivated Polio Vaccine Production (2020-2025)
9.6.1 Japan Inactivated Polio Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Inactivated Polio Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Inactivated Polio Vaccine Production (2020-2025)
9.7.1 China Inactivated Polio Vaccine Production Growth Rate (2020-2025)
9.7.2 China Inactivated Polio Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sanofi
10.1.1 Sanofi Basic Information
10.1.2 Sanofi Inactivated Polio Vaccine Product Overview
10.1.3 Sanofi Inactivated Polio Vaccine Product Market Performance
10.1.4 Sanofi Business Overview
10.1.5 Sanofi SWOT Analysis
10.1.6 Sanofi Recent Developments
10.2 GSK
10.2.1 GSK Basic Information
10.2.2 GSK Inactivated Polio Vaccine Product Overview
10.2.3 GSK Inactivated Polio Vaccine Product Market Performance
10.2.4 GSK Business Overview
10.2.5 GSK SWOT Analysis
10.2.6 GSK Recent Developments
10.3 Bibcol
10.3.1 Bibcol Basic Information
10.3.2 Bibcol Inactivated Polio Vaccine Product Overview
10.3.3 Bibcol Inactivated Polio Vaccine Product Market Performance
10.3.4 Bibcol Business Overview
10.3.5 Bibcol SWOT Analysis
10.3.6 Bibcol Recent Developments
10.4 Serum Institute
10.4.1 Serum Institute Basic Information
10.4.2 Serum Institute Inactivated Polio Vaccine Product Overview
10.4.3 Serum Institute Inactivated Polio Vaccine Product Market Performance
10.4.4 Serum Institute Business Overview
10.4.5 Serum Institute Recent Developments
10.5 Tiantan Biological
10.5.1 Tiantan Biological Basic Information
10.5.2 Tiantan Biological Inactivated Polio Vaccine Product Overview
10.5.3 Tiantan Biological Inactivated Polio Vaccine Product Market Performance
10.5.4 Tiantan Biological Business Overview
10.5.5 Tiantan Biological Recent Developments
10.6 Panacea Biotec
10.6.1 Panacea Biotec Basic Information
10.6.2 Panacea Biotec Inactivated Polio Vaccine Product Overview
10.6.3 Panacea Biotec Inactivated Polio Vaccine Product Market Performance
10.6.4 Panacea Biotec Business Overview
10.6.5 Panacea Biotec Recent Developments
10.7 Bio-Med
10.7.1 Bio-Med Basic Information
10.7.2 Bio-Med Inactivated Polio Vaccine Product Overview
10.7.3 Bio-Med Inactivated Polio Vaccine Product Market Performance
10.7.4 Bio-Med Business Overview
10.7.5 Bio-Med Recent Developments
10.8 Halfkin Bio-Pharmaceuticals
10.8.1 Halfkin Bio-Pharmaceuticals Basic Information
10.8.2 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Product Overview
10.8.3 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Product Market Performance
10.8.4 Halfkin Bio-Pharmaceuticals Business Overview
10.8.5 Halfkin Bio-Pharmaceuticals Recent Developments
11 INACTIVATED POLIO VACCINE MARKET FORECAST BY REGION
11.1 Global Inactivated Polio Vaccine Market Size Forecast
11.2 Global Inactivated Polio Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Inactivated Polio Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Inactivated Polio Vaccine Market Size Forecast by Region
11.2.4 South America Inactivated Polio Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Inactivated Polio Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Inactivated Polio Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Inactivated Polio Vaccine by Type (2026-2035)
12.1.2 Global Inactivated Polio Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Inactivated Polio Vaccine by Type (2026-2035)
12.2 Global Inactivated Polio Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Inactivated Polio Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Inactivated Polio Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Inactivated Polio Vaccine
1.2 Key Market Segments
1.2.1 Inactivated Polio Vaccine Segment by Type
1.2.2 Inactivated Polio Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INACTIVATED POLIO VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Inactivated Polio Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Inactivated Polio Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INACTIVATED POLIO VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Inactivated Polio Vaccine Product Life Cycle
3.3 Global Inactivated Polio Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Inactivated Polio Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Inactivated Polio Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Inactivated Polio Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Inactivated Polio Vaccine Market Competitive Situation and Trends
3.8.1 Inactivated Polio Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Inactivated Polio Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INACTIVATED POLIO VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Inactivated Polio Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INACTIVATED POLIO VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Inactivated Polio Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Inactivated Polio Vaccine Market
5.7 ESG Ratings of Leading Companies
6 INACTIVATED POLIO VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Inactivated Polio Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Inactivated Polio Vaccine Market Size by Type (2020-2025)
6.4 Global Inactivated Polio Vaccine Price by Type (2020-2025)
7 INACTIVATED POLIO VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Inactivated Polio Vaccine Market Sales by Application (2020-2025)
7.3 Global Inactivated Polio Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Inactivated Polio Vaccine Sales Growth Rate by Application (2020-2025)
8 INACTIVATED POLIO VACCINE MARKET SALES BY REGION
8.1 Global Inactivated Polio Vaccine Sales by Region
8.1.1 Global Inactivated Polio Vaccine Sales by Region
8.1.2 Global Inactivated Polio Vaccine Sales Market Share by Region
8.2 Global Inactivated Polio Vaccine Market Size by Region
8.2.1 Global Inactivated Polio Vaccine Market Size by Region
8.2.2 Global Inactivated Polio Vaccine Market Size by Region
8.3 North America
8.3.1 North America Inactivated Polio Vaccine Sales by Country
8.3.2 North America Inactivated Polio Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Inactivated Polio Vaccine Sales by Country
8.4.2 Europe Inactivated Polio Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Inactivated Polio Vaccine Sales by Region
8.5.2 Asia Pacific Inactivated Polio Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Inactivated Polio Vaccine Sales by Country
8.6.2 South America Inactivated Polio Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Inactivated Polio Vaccine Sales by Region
8.7.2 Middle East and Africa Inactivated Polio Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INACTIVATED POLIO VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Inactivated Polio Vaccine by Region(2020-2025)
9.2 Global Inactivated Polio Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Inactivated Polio Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Inactivated Polio Vaccine Production
9.4.1 North America Inactivated Polio Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Inactivated Polio Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Inactivated Polio Vaccine Production
9.5.1 Europe Inactivated Polio Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Inactivated Polio Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Inactivated Polio Vaccine Production (2020-2025)
9.6.1 Japan Inactivated Polio Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Inactivated Polio Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Inactivated Polio Vaccine Production (2020-2025)
9.7.1 China Inactivated Polio Vaccine Production Growth Rate (2020-2025)
9.7.2 China Inactivated Polio Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sanofi
10.1.1 Sanofi Basic Information
10.1.2 Sanofi Inactivated Polio Vaccine Product Overview
10.1.3 Sanofi Inactivated Polio Vaccine Product Market Performance
10.1.4 Sanofi Business Overview
10.1.5 Sanofi SWOT Analysis
10.1.6 Sanofi Recent Developments
10.2 GSK
10.2.1 GSK Basic Information
10.2.2 GSK Inactivated Polio Vaccine Product Overview
10.2.3 GSK Inactivated Polio Vaccine Product Market Performance
10.2.4 GSK Business Overview
10.2.5 GSK SWOT Analysis
10.2.6 GSK Recent Developments
10.3 Bibcol
10.3.1 Bibcol Basic Information
10.3.2 Bibcol Inactivated Polio Vaccine Product Overview
10.3.3 Bibcol Inactivated Polio Vaccine Product Market Performance
10.3.4 Bibcol Business Overview
10.3.5 Bibcol SWOT Analysis
10.3.6 Bibcol Recent Developments
10.4 Serum Institute
10.4.1 Serum Institute Basic Information
10.4.2 Serum Institute Inactivated Polio Vaccine Product Overview
10.4.3 Serum Institute Inactivated Polio Vaccine Product Market Performance
10.4.4 Serum Institute Business Overview
10.4.5 Serum Institute Recent Developments
10.5 Tiantan Biological
10.5.1 Tiantan Biological Basic Information
10.5.2 Tiantan Biological Inactivated Polio Vaccine Product Overview
10.5.3 Tiantan Biological Inactivated Polio Vaccine Product Market Performance
10.5.4 Tiantan Biological Business Overview
10.5.5 Tiantan Biological Recent Developments
10.6 Panacea Biotec
10.6.1 Panacea Biotec Basic Information
10.6.2 Panacea Biotec Inactivated Polio Vaccine Product Overview
10.6.3 Panacea Biotec Inactivated Polio Vaccine Product Market Performance
10.6.4 Panacea Biotec Business Overview
10.6.5 Panacea Biotec Recent Developments
10.7 Bio-Med
10.7.1 Bio-Med Basic Information
10.7.2 Bio-Med Inactivated Polio Vaccine Product Overview
10.7.3 Bio-Med Inactivated Polio Vaccine Product Market Performance
10.7.4 Bio-Med Business Overview
10.7.5 Bio-Med Recent Developments
10.8 Halfkin Bio-Pharmaceuticals
10.8.1 Halfkin Bio-Pharmaceuticals Basic Information
10.8.2 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Product Overview
10.8.3 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Product Market Performance
10.8.4 Halfkin Bio-Pharmaceuticals Business Overview
10.8.5 Halfkin Bio-Pharmaceuticals Recent Developments
11 INACTIVATED POLIO VACCINE MARKET FORECAST BY REGION
11.1 Global Inactivated Polio Vaccine Market Size Forecast
11.2 Global Inactivated Polio Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Inactivated Polio Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Inactivated Polio Vaccine Market Size Forecast by Region
11.2.4 South America Inactivated Polio Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Inactivated Polio Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Inactivated Polio Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Inactivated Polio Vaccine by Type (2026-2035)
12.1.2 Global Inactivated Polio Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Inactivated Polio Vaccine by Type (2026-2035)
12.2 Global Inactivated Polio Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Inactivated Polio Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Inactivated Polio Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Inactivated Polio Vaccine Market Size by Type (M USD)
Table 4. Global Inactivated Polio Vaccine Market Size by Application
Table 5. Inactivated Polio Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Inactivated Polio Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Inactivated Polio Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Inactivated Polio Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Inactivated Polio Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Polio Vaccine as of 2025)
Table 11. Global Market Inactivated Polio Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Inactivated Polio Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Inactivated Polio Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Inactivated Polio Vaccine Sales by Type (K MT)
Table 27. Global Inactivated Polio Vaccine Market Size by Type (M USD)
Table 28. Global Inactivated Polio Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Inactivated Polio Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Inactivated Polio Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Inactivated Polio Vaccine Market Share by Type (2020-2025)
Table 32. Global Inactivated Polio Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Inactivated Polio Vaccine Sales (K MT) by Application
Table 34. Global Inactivated Polio Vaccine Market Size by Application
Table 35. Global Inactivated Polio Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Inactivated Polio Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Inactivated Polio Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Inactivated Polio Vaccine Market Share by Application (2020-2025)
Table 39. Global Inactivated Polio Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Inactivated Polio Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Inactivated Polio Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Inactivated Polio Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Inactivated Polio Vaccine Market Size by Region (2020-2025)
Table 44. North America Inactivated Polio Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Inactivated Polio Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Inactivated Polio Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Inactivated Polio Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Inactivated Polio Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Inactivated Polio Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Inactivated Polio Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Inactivated Polio Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Inactivated Polio Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Inactivated Polio Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Inactivated Polio Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Inactivated Polio Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Inactivated Polio Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Inactivated Polio Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Inactivated Polio Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Inactivated Polio Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Inactivated Polio Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Inactivated Polio Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sanofi Basic Information
Table 63. Sanofi Inactivated Polio Vaccine Product Overview
Table 64. Sanofi Inactivated Polio Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sanofi Business Overview
Table 66. Sanofi SWOT Analysis
Table 67. Sanofi Recent Developments
Table 68. GSK Basic Information
Table 69. GSK Inactivated Polio Vaccine Product Overview
Table 70. GSK Inactivated Polio Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GSK Business Overview
Table 72. GSK SWOT Analysis
Table 73. GSK Recent Developments
Table 74. Bibcol Basic Information
Table 75. Bibcol Inactivated Polio Vaccine Product Overview
Table 76. Bibcol Inactivated Polio Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Bibcol Business Overview
Table 78. Bibcol SWOT Analysis
Table 79. Bibcol Recent Developments
Table 80. Serum Institute Basic Information
Table 81. Serum Institute Inactivated Polio Vaccine Product Overview
Table 82. Serum Institute Inactivated Polio Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Serum Institute Business Overview
Table 84. Serum Institute Recent Developments
Table 85. Tiantan Biological Basic Information
Table 86. Tiantan Biological Inactivated Polio Vaccine Product Overview
Table 87. Tiantan Biological Inactivated Polio Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Tiantan Biological Business Overview
Table 89. Tiantan Biological Recent Developments
Table 90. Panacea Biotec Basic Information
Table 91. Panacea Biotec Inactivated Polio Vaccine Product Overview
Table 92. Panacea Biotec Inactivated Polio Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Panacea Biotec Business Overview
Table 94. Panacea Biotec Recent Developments
Table 95. Bio-Med Basic Information
Table 96. Bio-Med Inactivated Polio Vaccine Product Overview
Table 97. Bio-Med Inactivated Polio Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Bio-Med Business Overview
Table 99. Bio-Med Recent Developments
Table 100. Halfkin Bio-Pharmaceuticals Basic Information
Table 101. Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Product Overview
Table 102. Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Halfkin Bio-Pharmaceuticals Business Overview
Table 104. Halfkin Bio-Pharmaceuticals Recent Developments
Table 105. Global Inactivated Polio Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 106. Global Inactivated Polio Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 107. North America Inactivated Polio Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 108. North America Inactivated Polio Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 109. Europe Inactivated Polio Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 110. Europe Inactivated Polio Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 111. Asia Pacific Inactivated Polio Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 112. Asia Pacific Inactivated Polio Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 113. South America Inactivated Polio Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 114. South America Inactivated Polio Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 115. Middle East and Africa Inactivated Polio Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 116. Middle East and Africa Inactivated Polio Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 117. Global Inactivated Polio Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 118. Global Inactivated Polio Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 119. Global Inactivated Polio Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 120. Global Inactivated Polio Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 121. Global Inactivated Polio Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Inactivated Polio Vaccine Market Size by Type (M USD)
Table 4. Global Inactivated Polio Vaccine Market Size by Application
Table 5. Inactivated Polio Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Inactivated Polio Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Inactivated Polio Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Inactivated Polio Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Inactivated Polio Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Polio Vaccine as of 2025)
Table 11. Global Market Inactivated Polio Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Inactivated Polio Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Inactivated Polio Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Inactivated Polio Vaccine Sales by Type (K MT)
Table 27. Global Inactivated Polio Vaccine Market Size by Type (M USD)
Table 28. Global Inactivated Polio Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Inactivated Polio Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Inactivated Polio Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Inactivated Polio Vaccine Market Share by Type (2020-2025)
Table 32. Global Inactivated Polio Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Inactivated Polio Vaccine Sales (K MT) by Application
Table 34. Global Inactivated Polio Vaccine Market Size by Application
Table 35. Global Inactivated Polio Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Inactivated Polio Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Inactivated Polio Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Inactivated Polio Vaccine Market Share by Application (2020-2025)
Table 39. Global Inactivated Polio Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Inactivated Polio Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Inactivated Polio Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Inactivated Polio Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Inactivated Polio Vaccine Market Size by Region (2020-2025)
Table 44. North America Inactivated Polio Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Inactivated Polio Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Inactivated Polio Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Inactivated Polio Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Inactivated Polio Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Inactivated Polio Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Inactivated Polio Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Inactivated Polio Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Inactivated Polio Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Inactivated Polio Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Inactivated Polio Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Inactivated Polio Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Inactivated Polio Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Inactivated Polio Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Inactivated Polio Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Inactivated Polio Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Inactivated Polio Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Inactivated Polio Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sanofi Basic Information
Table 63. Sanofi Inactivated Polio Vaccine Product Overview
Table 64. Sanofi Inactivated Polio Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sanofi Business Overview
Table 66. Sanofi SWOT Analysis
Table 67. Sanofi Recent Developments
Table 68. GSK Basic Information
Table 69. GSK Inactivated Polio Vaccine Product Overview
Table 70. GSK Inactivated Polio Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GSK Business Overview
Table 72. GSK SWOT Analysis
Table 73. GSK Recent Developments
Table 74. Bibcol Basic Information
Table 75. Bibcol Inactivated Polio Vaccine Product Overview
Table 76. Bibcol Inactivated Polio Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Bibcol Business Overview
Table 78. Bibcol SWOT Analysis
Table 79. Bibcol Recent Developments
Table 80. Serum Institute Basic Information
Table 81. Serum Institute Inactivated Polio Vaccine Product Overview
Table 82. Serum Institute Inactivated Polio Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Serum Institute Business Overview
Table 84. Serum Institute Recent Developments
Table 85. Tiantan Biological Basic Information
Table 86. Tiantan Biological Inactivated Polio Vaccine Product Overview
Table 87. Tiantan Biological Inactivated Polio Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Tiantan Biological Business Overview
Table 89. Tiantan Biological Recent Developments
Table 90. Panacea Biotec Basic Information
Table 91. Panacea Biotec Inactivated Polio Vaccine Product Overview
Table 92. Panacea Biotec Inactivated Polio Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Panacea Biotec Business Overview
Table 94. Panacea Biotec Recent Developments
Table 95. Bio-Med Basic Information
Table 96. Bio-Med Inactivated Polio Vaccine Product Overview
Table 97. Bio-Med Inactivated Polio Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Bio-Med Business Overview
Table 99. Bio-Med Recent Developments
Table 100. Halfkin Bio-Pharmaceuticals Basic Information
Table 101. Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Product Overview
Table 102. Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Halfkin Bio-Pharmaceuticals Business Overview
Table 104. Halfkin Bio-Pharmaceuticals Recent Developments
Table 105. Global Inactivated Polio Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 106. Global Inactivated Polio Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 107. North America Inactivated Polio Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 108. North America Inactivated Polio Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 109. Europe Inactivated Polio Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 110. Europe Inactivated Polio Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 111. Asia Pacific Inactivated Polio Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 112. Asia Pacific Inactivated Polio Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 113. South America Inactivated Polio Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 114. South America Inactivated Polio Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 115. Middle East and Africa Inactivated Polio Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 116. Middle East and Africa Inactivated Polio Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 117. Global Inactivated Polio Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 118. Global Inactivated Polio Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 119. Global Inactivated Polio Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 120. Global Inactivated Polio Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 121. Global Inactivated Polio Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Inactivated Polio Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Inactivated Polio Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Inactivated Polio Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Inactivated Polio Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Inactivated Polio Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Inactivated Polio Vaccine Product Life Cycle
Figure 13. Inactivated Polio Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Inactivated Polio Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Inactivated Polio Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Inactivated Polio Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Inactivated Polio Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Inactivated Polio Vaccine
Figure 19. Global Inactivated Polio Vaccine Market PEST Analysis
Figure 20. Global Inactivated Polio Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Inactivated Polio Vaccine Market Share by Type
Figure 27. Sales Market Share of Inactivated Polio Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Inactivated Polio Vaccine by Type in 2025
Figure 29. Market Share of Inactivated Polio Vaccine by Type (2020-2025)
Figure 30. Market Share of Inactivated Polio Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Inactivated Polio Vaccine Market Share by Application
Figure 33. Global Inactivated Polio Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Inactivated Polio Vaccine Sales Market Share by Application in 2025
Figure 35. Global Inactivated Polio Vaccine Market Share by Application (2020-2025)
Figure 36. Global Inactivated Polio Vaccine Market Share by Application in 2025
Figure 37. Global Inactivated Polio Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Inactivated Polio Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Inactivated Polio Vaccine Market Size by Region (2020-2025)
Figure 40. North America Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Inactivated Polio Vaccine Sales Market Share by Country in 2024
Figure 43. North America Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Inactivated Polio Vaccine Market Size by Country in 2024
Figure 45. U.S. Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Inactivated Polio Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Inactivated Polio Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Inactivated Polio Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Inactivated Polio Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Inactivated Polio Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Inactivated Polio Vaccine Market Size by Country in 2024
Figure 55. Germany Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Inactivated Polio Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Inactivated Polio Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Inactivated Polio Vaccine Market Size by Region in 2024
Figure 68. China Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Inactivated Polio Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Inactivated Polio Vaccine Sales Market Share by Country in 2024
Figure 80. South America Inactivated Polio Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Inactivated Polio Vaccine Market Size by Country in 2024
Figure 82. Brazil Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Inactivated Polio Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Inactivated Polio Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Inactivated Polio Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Inactivated Polio Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Inactivated Polio Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Inactivated Polio Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Inactivated Polio Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Inactivated Polio Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Inactivated Polio Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Inactivated Polio Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Inactivated Polio Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Inactivated Polio Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Inactivated Polio Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Inactivated Polio Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Inactivated Polio Vaccine Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Inactivated Polio Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Inactivated Polio Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Inactivated Polio Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Inactivated Polio Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Inactivated Polio Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Inactivated Polio Vaccine Product Life Cycle
Figure 13. Inactivated Polio Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Inactivated Polio Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Inactivated Polio Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Inactivated Polio Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Inactivated Polio Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Inactivated Polio Vaccine
Figure 19. Global Inactivated Polio Vaccine Market PEST Analysis
Figure 20. Global Inactivated Polio Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Inactivated Polio Vaccine Market Share by Type
Figure 27. Sales Market Share of Inactivated Polio Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Inactivated Polio Vaccine by Type in 2025
Figure 29. Market Share of Inactivated Polio Vaccine by Type (2020-2025)
Figure 30. Market Share of Inactivated Polio Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Inactivated Polio Vaccine Market Share by Application
Figure 33. Global Inactivated Polio Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Inactivated Polio Vaccine Sales Market Share by Application in 2025
Figure 35. Global Inactivated Polio Vaccine Market Share by Application (2020-2025)
Figure 36. Global Inactivated Polio Vaccine Market Share by Application in 2025
Figure 37. Global Inactivated Polio Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Inactivated Polio Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Inactivated Polio Vaccine Market Size by Region (2020-2025)
Figure 40. North America Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Inactivated Polio Vaccine Sales Market Share by Country in 2024
Figure 43. North America Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Inactivated Polio Vaccine Market Size by Country in 2024
Figure 45. U.S. Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Inactivated Polio Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Inactivated Polio Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Inactivated Polio Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Inactivated Polio Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Inactivated Polio Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Inactivated Polio Vaccine Market Size by Country in 2024
Figure 55. Germany Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Inactivated Polio Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Inactivated Polio Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Inactivated Polio Vaccine Market Size by Region in 2024
Figure 68. China Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Inactivated Polio Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Inactivated Polio Vaccine Sales Market Share by Country in 2024
Figure 80. South America Inactivated Polio Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Inactivated Polio Vaccine Market Size by Country in 2024
Figure 82. Brazil Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Inactivated Polio Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Inactivated Polio Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Inactivated Polio Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Inactivated Polio Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Inactivated Polio Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Inactivated Polio Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Inactivated Polio Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Inactivated Polio Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Inactivated Polio Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Inactivated Polio Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Inactivated Polio Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Inactivated Polio Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Inactivated Polio Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Inactivated Polio Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Inactivated Polio Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Inactivated Polio Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Inactivated Polio Vaccine Market Share Forecast by Application (2026-2035)
